Imaging thrives by making connections
The first six months of 2008 demonstrated the connectivity of diagnostic imaging.
The first six months of 2008 demonstrated the connectivity of diagnostic imaging.
Groundbreaking clinical research often has a multifaceted influence. It may establish or confirm the efficacy of a promising imaging application to foster its clinical adoption. It can sway opinion among Medicare policymakers to determine if, when, and under what conditions new procedures will gain routine reimbursement.
Study results can light a fire under healthcare advocacy groups, encouraging them to rally their forces behind new and better ways to diagnose disease. And political controversies can stir radiology's governing bodies to take action or lead critics of medical imaging to question the credibility of investigations involving years of data collection and analysis.
Such interrelationships have been the hallmark of imaging research news so far this year. From developments in multislice coronary CT to molecular imaging applications monitored by the National Oncologic PET Registry they demonstrate the ongoing success and growing diagnostic power of medical imaging.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
